Flexomics helps to bridge genomic and functional analysis.
Flexomics has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in July 2022.
Flexomics's investors include National Cancer Institute SBIR Development Center.
Flexomics is headquartered in Boston, United States.
Flexomics helps to bridge genomic and functional analysis.
Flexomics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Flexomics — Funding & Investors." VCBacked, July 12, 2022, https://www.vcbacked.co/company/flexomics. Accessed August 13, 2026.
VCBacked. (2022). Flexomics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/flexomics
{{cite web |title=Flexomics — Funding & Investors |url=https://www.vcbacked.co/company/flexomics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated